Open official notice

Cessation of implantation and market withdrawal of the CyPass™ Micro Stent, because increased endothelial cell loss has been detected in a postmarketing study when it is implanted in combination with cataract surgery.

Official notice

10 Sept 2018

Last checked

26 Oct 2026

RecallScope risk estimate:Not specifiedAEMPS

An official AEMPS notice concerns Cessation of implantation and market withdrawal of the CyPass™ Micro Stent, because increased endothelial cell loss has been detected in a postmarketing study when it is implanted in combination with cataract surgery.. Cessation of implantation and market withdrawal of the CyPass™ Micro Stent, because increased endothelial cell loss has been detected in a postmarketing study when it is implanted in combination with cataract surgery. Recommendations for follow-up of patients with implants. Published 2018-09-10.

What to do now

After consulting its network of ophthalmology experts, AEMPS considers the company's general measures to withdraw the CyPass micro stent and cease implantation appropriate. However, regarding recommendations for follow-up of patients with implants, performing the maneuver to trim the stent is discouraged, as this is a highly complex technique that could cause additional endothelial damage. AEMPS has requested additional information from the company to assess the problem described and the recommendations on actions healthcare professionals should take. In this situation, the alert and the company's information notice are being issued, without prejudice to AEMPS issuing further recommendations.

Recall number

2018-478

Official notice

2018-09-10

The hazard

Cessation of implantation and market withdrawal of the CyPass™ Micro Stent, because increased endothelial cell loss has been detected in a postmarketing study when it is implanted in combination with cataract surgery. Recommendations for follow-up of patients with implants.

How to check if you're affected

Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.

Other

PS/FFG/47679

Recall Numbers

2018-478

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

Micro Stent CyPass®

Hazard

Cessation of implantation and market withdrawal of the CyPass™ Micro Stent, because increased endothelial cell loss has been detected in a postmarketing study when it is implanted in combination with cataract surgery. Recommendations for follow-up of patients with implants.

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

ES · Spain

Affected area 1

ES · Spain

Source & status

Source

Tier

official

Category

HEALTH

Official classification

AEMPS — Alerta de productos sanitarios (tipo 1A)

Recall details

Recall number

2018-478

Event id

2018-478

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 10 Sept 2018. The next one won't wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button